J. L. Chico-García

发表

Non‐severe immunosuppression might be associated with a lower risk of moderate–severe acute respiratory distress syndrome in COVID‐19: A pilot study

J. López-Sendón, R. Toledano, J. Masjuán, 2020, Journal of medical virology.

Efficacy and safety of high doses of safinamide in advanced Parkinson disease.

I. Parees, J. Pagonabarraga, J. C. Martínez‐Castrillo, 2022, Parkinsonism & related disorders.

Acute‐onset smell and taste disorders in the context of COVID‐19: a pilot multicentre polymerase chain reaction based case–control study

J. Masjuán, Álvaro Beltrán-Corbellini, J. Porta‐Etessam, 2020, European journal of neurology.

The effect of timing of high-efficacy therapy on processing speed performance in multiple sclerosis.

A. Labiano-Fontcuberta, S. Sainz de la Maza, L. Costa-Frossard, 2022, Multiple sclerosis and related disorders.

Non-severe immunosuppression might be associated with a lower risk of moderate-severe acute respiratory distress syndrome in COVID-19.

J. López-Sendón, R. Toledano, J. Masjuán, 2020 .

Immunosuppression is associated with a lower risk of moderate to severe acute respiratory distress syndrome in COVID-19.

J. López-Sendón, R. Toledano, J. Masjuán, 2020 .

B-lymphocyte-guided retreatment contributes to establish good effectiveness and safety profile in MS patients treated with rituximab.

E. Rodríguez-Martín, J. Masjuán, E. Roldán, 2022, Multiple sclerosis and related disorders.

Malignant Left Atrial Appendage Morphology: Current Classification vs H-L System.

J. Masjuán, Álvaro Beltrán-Corbellini, A. Cruz-Culebras, 2020, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

High versus standard doses of corticosteroids in severe COVID-19: a retrospective cohort study

R. Toledano, J. Masjuán, A. Muriel, 2020, European Journal of Clinical Microbiology & Infectious Diseases.

Use of the Cardiovascular Polypill in Secondary Prevention of Cerebrovascular Disease: A Real-Life Tertiary Hospital Cohort Study of 104 Patients

J. Masjuán, A. Cruz-Culebras, A. de Felipe Mimbrera, 2020, Cerebrovascular Diseases Extra.

Does the Country Make a Difference in Impulse Control Disorders? A Systematic Review

J. C. Martínez‐Castrillo, P. Parra-Díaz, A. Alonso-Canovas, 2020, Movement disorders clinical practice.

Short- and Long-Term Humoral and Cellular Immune Responses to SARS-CoV-2 Vaccination in Patients with Multiple Sclerosis Treated with Disease-Modifying Therapies

J. Masjuán, N. Villarrubia, L. Villar, 2023, Vaccines.

Association of Serum Neurofilament Light Chain Levels at Disease Onset With Disability Worsening in Patients With a First Demyelinating Multiple Sclerosis Event Not Treated With High-Efficacy Drugs.

X. Montalban, M. Tintoré, L. Ramió-Torrentá, 2023, JAMA neurology.

Cenobamate in patients with highly refractory focal epilepsy: A retrospective real-world study

R. Toledano, A. Gil-Nagel, I. García-Morales, 2023, Seizure: European Journal of Epilepsy.

Blood CD8+ Naïve T-Cells Identify MS Patients with High Probability of Optimal Cellular Response to SARS-CoV-2 Vaccine

J. Masjuán, N. Villarrubia, L. Villar, 2023, Vaccines.

Establishing the best combination of the kappa free light chain index and oligoclonal bands for an accurate diagnosis of multiple sclerosis

N. Villarrubia, S. Sainz de la Maza, L. Costa-Frossard, 2023, Frontiers in immunology.

Passive assessment of tapping speed through smartphone is useful for monitoring multiple sclerosis.

E. Monreal, J. L. Chico-García, Fernando Rodríguez-Jorge, 2024, Multiple sclerosis and related disorders.